Skip to main content
Equibles

Sheldon Koenig

CEO

Esperion Therapeutics, Inc.

COO

Esperion Therapeutics, Inc.

Board Member

Esperion Therapeutics, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sheldon Koenig

Sheldon Koenig is recorded as CEO, COO and Board Member at Esperion Therapeutics, Inc.. Sheldon Koenig has spoken on 20 earnings calls across 1 company, most recently for Esperion Therapeutics, Inc. on March 10, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Esperion Therapeutics, Inc.

    Board Member

    SEC 8-K

    Current

    2021-05-18–present

  • Esperion Therapeutics, Inc.

    CEO

    Proxy statement

    Current

  • Esperion Therapeutics, Inc.

    COO

    Proxy statement

    Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Esperion Therapeutics, Inc.

Current role

CEO, COO, Board Member

2021-05-18–present

20 appearances Latest appearance 2026-03-10

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2025 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q3 FY2025 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q2 FY2025 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q1 FY2025 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2024 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q3 FY2024 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q2 FY2024 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q1 FY2024 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2023 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q3 FY2023 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q2 FY2023 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q1 FY2023 Earnings Call

    Esperion Therapeutics, Inc.

Show 8 earlier activities
  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2022 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q3 FY2022 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q2 FY2022 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q1 FY2022 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2021 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q3 FY2021 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q2 FY2021 Earnings Call

    Esperion Therapeutics, Inc.

  • Earnings call

    Esperion Therapeutics, Inc. Q4 FY2020 Earnings Call

    Esperion Therapeutics, Inc.